$MAC

Macerich (NYSE:MAC) Stock Rating Upgraded by JPMorgan Chase & Co.

JPMorgan upgraded Macerich (NYSE:MAC) from “underweight” to “neutral” and set a $25.00 price target, implying 5.34% upside from the prior close, according to MarketBeat. Other firms cited include Deutsche Bank (to “buy,” $27 target) and Goldman Sachs (to “sell,” $19 target). Macerich reported $0.34 EPS and $241.54M revenue for Q ended May 6.

Original reporting
Published Jun 17, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 2:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Macerich (NYSE:MAC) Stock Rating Upgraded by JPMorgan Chase & Co. — source image
Decision brief

The 30-second read

$MACBullishMed
01

Why it matters

The newest actionable item is JPMorgan’s upgrade to neutral with a $25 target; other firms’ prior target changes are listed but not newly disclosed in this article.

02

Market read

Traders may use the upgrade/target to reassess near-term downside risk and potential mean reversion after a down session, while monitoring whether fundamentals/rates validate the improved sentiment.

03

What to watch

The article aggregates multiple analyst actions (some bullish, some bearish) but does not quantify which view dominates positioning; also, the REIT’s leverage/liquidity ratios (debt-to-equity 1.96; current/quick 0.83) could cap upside if rates or credit conditions worsen.

Relevance 7/10Novelty 4/10Timing: Upgrade report released Wednesday; stock trading down 5.4% in the same session

Background

Macerich is a regional shopping-center REIT; the piece centers on sell-side rating changes and reiterates recent earnings metrics from May 6.

Company-level read

Ticker impact

$MACBullishMedium confidence
Context

JPMorgan upgraded Macerich from underweight to neutral and set a $25 target, implying ~5.34% upside from the prior close.

Expected impact

Likely modest upside bias/mean-reversion support versus recent weakness, with follow-through dependent on REIT fundamentals and broader market rates.

Evidence & confidence

The article provides a concrete upgrade and target ($25) plus recent trading down 5.4%, but it does not introduce new operational catalysts beyond the already-reported May 6 earnings.

Market effects

Incremental sentiment support for shopping-center REITs via renewed analyst neutrality/targets, but no sector-wide policy or rate catalyst is disclosed.

No regional demand or property-specific developments are provided.

No cross-border or macro shock is mentioned; impact is primarily single-name sentiment.

Counterpoint

Despite the upgrade, the stock’s valuation/profitability signals remain weak (negative net margin and ROE), so the rating change may not translate into sustained outperformance.

Key entities

  • Macerich

    REIT subject of the JPMorgan upgrade and the article’s trading/earnings recap.

  • JPMorgan Chase & Co.

    Upgraded MAC from underweight to neutral and set a $25 price target.

Related articles

$MACMed

Macerich (MAC) Q2 2026 Earnings Call Transcript

Macerich (MAC) reported Q2 2026 results on an earnings call. Adjusted FFO was $0.35 per diluted share, with go-forward portfolio NOI up 3.8%. SNO pipeline was $124 million. Leased occupancy was 94% for the portfolio and 95.5% for the go-forward portfolio. Portfolio sales were $919 per sq ft, $954 for go-forward. The company said it has $372 million available for acquisitions.

$MACMedAI 8/10

Macerich Company: Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031

Macerich (NYSE: MAC) priced an upsized $675 million offering of 2.25% exchangeable senior notes due 2031, up from $600 million. The notes settle Aug. 11, 2026, pay 2.25% semiannually, mature Aug. 15, 2031, and are exchangeable into MAC shares at an initial rate of 35.4761 shares per $1,000 principal. Net proceeds are about $659.1 million.

$MACMed

The Macerich Company Q2 2026 Earnings Call Summary

Macerich reported progress on its Path Forward 3.0 plan, with leasing completion at 88% versus a midyear 85% target. Management reiterated 2026 go-forward portfolio NOI growth of at least 3%, accelerating to 3.5%+ in 2H, and expects >8% NOI growth in 2027-28 as a $140 million SNO pipeline contributes rent. Net debt/adj. EBITDA improved to 7.3x. The company plans $372 million of unsettled forward equity for acquisitions and noted a $76 million loan default at 29th Street.

$MACMed

Mall Giant Macerich Narrows Losses in Q2 Amid Stronger Leasing

Macerich (a mall REIT) reported Q2 leased occupancy of 94% (up from 92% a year earlier) after signing about 1.3 million sq ft of new and renewal leases. Lease revenue was $233.4M and total revenue $249.7M. Adjusted FFO was $100.4M. Net loss narrowed to $27.1M from nearly $41M, helped by asset sales. Go-forward NOI rose 3.8% and the company cited $1.2B liquidity.

$MACMed

MACERICH CO (MAC): Results of Operations and Financial Condition

MACERICH CO (MAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2-exhibit991.htm EX-99.1 2026 Q2- Exhibit 99.1 Exhibit 99.1 Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 2026 The Macerich Company Earnings Results & Supplemental Information For the Three and Six Months Ended June 30, 20

$MACMed

Macerich Announces Commencement of Public Offering of Common Stock

Macerich (NYSE: MAC) said it has started an underwritten public offering of 14,000,000 shares of common stock, with Goldman Sachs & Co. LLC as lead bookrunner. The underwriters have a 30-day option to buy up to 2,100,000 additional shares. Macerich expects to enter forward sale agreements with financial institutions; it will not receive initial proceeds, with net proceeds expected upon future settlement to fund acquisitions and general corporate purposes.